Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

Genetics, autoantibodies and clinical features in understanding and

predicting rheumatoid arthritis

Helm-van Mil, A.H.M. van der

Citation

Helm-van Mil, A. H. M. van der. (2006, October 26). Genetics, autoantibodies and clinical

features in understanding and predicting rheumatoid arthritis. Retrieved from

https://hdl.handle.net/1887/4929

Version:

Corrected Publisher’s Version

License:

Licence agreement concerning inclusion of doctoral thesis in the

_{Institutional Repository of the University of Leiden}

Downloaded from:

https://hdl.handle.net/1887/4929

!SSOCIATION¬BETWEEN¬040.¬#4¬AND¬2! 

!¬MISSENSE¬3.0¬RS¬#4 ¬IN¬040.¬WHICH¬ENCODES¬A¬TYROSINE¬PHOSPHATASE¬ HAS¬ BEEN¬ ASSOCIATED¬ WITH¬ MULTIPLE¬ AUTOIMMUNE¬ DISEASES¬ INCLUDING¬ 2!¬   ¬ 4HIS¬ 3.0¬ RESULTS¬IN¬THE¬SUBSTITUTION¬OF¬A¬CONSERVED¬ARGININE¬WITH¬TRYPTOPHAN¬AT¬CODON¬¬27 IN¬THE¬PROTEINS¬3(  BINDING¬DOMAIN¬4HE¬4¬RISK¬ALLELE¬WHICH¬RESULTS¬IN¬DISRUPTION¬ OF¬THE¬INTERACTION¬BETWEEN¬040.¬AND¬THE¬# 3RC¬KINASE¬#SK¬ ¬POTENTIALLY¬ALTERS¬THESE PROTEINS¬FUNCTION¬AS¬NEGATIVE¬REGULATORS¬OF¬4 CELL¬ACTIVATION¬)N¬THIS¬STUDY¬WE¬INVESTGATE¬ THE¬ASSOCIATION¬OF¬THE 040. #4¬3.0¬WITH¬2!¬UNDIFFERENTIATED¬ARTHRITIS¬5! ¬AND BOTH¬QUANTITATIVE¬RATE¬OF¬JOINT¬DESTRUCTION ¬AND¬QUALITATIVE¬AUTOANTIBODY¬STATUS¬AND¬RE MISSION¬OR¬PROGRESSION ¬2!¬CHARACTERISTICS !LL¬2!¬CASES¬N ¬WERE¬PARTICIPANTS¬IN¬THE¬,EIDEN¬%ARLY¬!RTHRITIS¬#LINIC¬%!# ¬A¬POPU LATION BASED INCEPTION¬ COHORT¬ OF¬ RECENT¬ ONSET¬ ARTHRITIS¬ DESCRIBED¬ BY¬ VAN¬ !KEN¬ ET¬ AL¬   AND¬FULl¬LLED¬!#2¬CRITERIA¬FOR¬2!¬AT¬ONE¬YEAR¬FOLLOW UP¬%!#¬PARTICIPANTS¬WHO¬COULD¬NOT BE¬PROPERLY¬CLASSIl¬ED¬AT¬ONE¬YEAR¬N ¬WERE¬CATEGORIZED¬AS¬5!¬CASES¬!LL¬PATIENTS¬AND¬ UNRELATED¬CONTROL¬INDIVIDUALS¬DESCRIBED¬IN¬REFERENCE¬ ¬WERE¬$UTCH¬WHITES¬!PPROPRIATE¬ INSTITUTIONAL¬REVIEW¬BOARDS¬APPROVED¬THE¬PROTOCOL

!SSOCIATION¬BETWEEN¬040.¬#4¬AND¬2! 

AT¬INCREASED¬RISK¬FOR¬2&¬POSITIVE¬P ¬AND¬ANTI ##0¬POSITIVE¬2!¬ ¬4HIS¬WAS¬ NOT¬ THE¬ CASE¬ FOR¬ AUTOANTIBODY¬ NEGATIVE¬ PATIENTS¬ SUGGESTING¬ AN¬ ASSOCIATION¬ BETWEEN¬ THE 040. 4¬RISK¬ALLELE¬AND¬AUTOANTIBODY¬PRODUCTION¬IN¬2!¬#ONSISTENT¬WITH¬PREVIOUS¬ STUDIES¬   ¬ 040. #4¬ GENOTYPE¬ FREQUENCIES¬ WERE¬ SIMILAR¬ IN¬ (,! $2"¬ SHARED¬ EPITOPE¬3% POSITIVE¬AND¬3% NEGATIVE¬CASES¬¬VS¬¬P ¬SUGGESTING¬THAT¬ THE 040. RISK¬ ALLELE¬ ACTS¬ INDEPENDENTLY¬ OF¬ (,! $2"¬ SUSCEPTIBLE¬ ALLELES¬ TO¬ INm¬UENCE¬ 2!¬RISK

!SSOCIATION¬BETWEEN¬040.¬#4¬AND¬2! 

2%&%2%.#%3

¬ ¬ "EGOVICH¬!"¬#ARLTON¬6%(¬(ONIGBERG¬,!¬3CHRODI¬3*¬#HOKKALINGAM¬!0¬!LEXANDER¬(# ET¬ AL¬ !¬ -ISSENSE¬ SINGLE NUCLEOTIDE¬ POLYMORPHISM¬ IN¬ A¬ GENE¬ ENCODING¬ A¬ PROTEIN¬ TRYO SINE¬ PHOSPHATASE¬ 040. ¬ IS¬ ASSOCIATED¬ WITH¬ RHEUMATOID¬ ARTHRITIS¬ !M¬ *¬ (UM¬ 'ENET   ¬ ¬¬ 'REGERSEN¬0¬0ATHWAYS¬TO¬GENE¬IDENTIl¬CATION¬IN¬RHEUMATOID¬ARTHRITIS¬040.¬AND¬BE YOND¬)MMUNOL¬2EV¬¬  ¬ ¬¬ "OTTINI¬.¬-USUMECI¬,¬!LONSO¬!¬2AHMOUNI¬3¬.IKA¬+¬2OSTAMKHANI¬-¬ET¬AL¬!¬FUNC TIONAL¬VARIANT¬OF¬LYMPHOID¬TYROSINE¬PHOSPHATASE¬IS¬ASSOCIATED¬WITH¬TYPE¬)¬DIABETES¬.AT 'ENET¬  

¬ ¬¬ VAN¬ !KEN¬ *¬ VAN¬ "ILSEN¬ *(¬ !LLAART¬ #&¬ (UIZINGA¬ 47¬ "REEDVELD¬ &#¬ 4HE¬ ,EIDEN¬ %ARLY !RTHRITIS¬#LINIC¬#LIN%XP2HEUMATOL¬3  ¬ ¬ VAN¬DER¬-EER¬&*¬+OSTER¬4¬6ANDENBROUCKE¬*0¬"RIET¬%¬2OSENDAAL¬&2¬4HE¬,EIDEN¬4HROM BOPHILIA¬3TUDY¬,%43 ¬4HROMB¬(AEMOST¬  ¬ ¬ 6ERDUYN¬7¬$OXIADIS¬))¬!NHOLTS¬*¬$RABBELS¬**¬.AIPAL¬!¬$!MARO¬*¬ET¬AL¬"IOTINYLATED¬ $2"¬SEQUENCE SPECIl¬C¬OLIGONUCLEOTIDES¬#OMPARISON¬TO¬SEROLOGIC¬(,! $2¬TYPING¬OF¬OR GAN¬DONORS¬IN¬EUROTRANSPLANT¬(UM¬)MMUNOL¬¬-AY¬ ¬ 

¬ ¬ VAN¬ DER¬ (ELM VAN¬ -IL¬ !(¬ $IEUDE¬ 0¬ 3CHONKEREN¬ **¬ #ORNELIS¬ &¬ (UIZINGA¬ 47¬ .O¬ AS SOCIATION¬BETWEEN¬TUMOUR¬NECROSIS¬FACTOR¬RECEPTOR¬TYPE¬¬GENE¬POLYMORPHISM¬AND¬RHEU MATOID¬ARTHRITIS¬SEVERITY¬A¬COMPARISON¬OF¬THE¬EXTREMES¬OF¬PHENOTYPES¬2HEUMATOLOGY¬